Resultados de la búsqueda 401-410 of 12603 for Herpes labialis

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This research study is being done to look at new MRI imaging guidance software, Philips Interventional iSuite software, to see if using will improve the ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    This trial will also study the outcomes of patients with mixed phenotype acute leukemia (MPAL) and disseminated B lymphoblastic lymphoma (B-LLy) when treated ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid (CSF) leak in ...

  4. Colitis seudomembranosa

    Jagirdhar GSK, et al. Non-clostridium difficile induced pseudomembranous colitis. World Journal of Clinical Cases. 2023; doi:10.12998/wjcc.v11.i5.979.

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...

  7. Mayo Clinic

    Share · Tweet . VID-20177816. Inicio; YouTube-ENT Tests FEES Video Swallow Study MLB. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...